A detailed history of Sage View Advisory Group, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Sage View Advisory Group, LLC holds 5,972 shares of ZTS stock, worth $1.14 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,972
Holding current value
$1.14 Million
% of portfolio
0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $869,164 - $1.07 Million
5,972 New
5,972 $1.04 Billion
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $70,268 - $92,841
464 Added 9.12%
5,553 $1.06 Billion
Q3 2023

Nov 02, 2023

BUY
$167.14 - $192.77 $245,862 - $283,564
1,471 Added 40.66%
5,089 $885 Million
Q2 2023

Aug 11, 2023

BUY
$160.94 - $186.23 $84,493 - $97,770
525 Added 16.97%
3,618 $623 Million
Q1 2023

May 01, 2023

BUY
$145.48 - $175.02 $449,969 - $541,336
3,093 New
3,093 $515 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $89.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Sage View Advisory Group, LLC Portfolio

Follow Sage View Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage View Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage View Advisory Group, LLC with notifications on news.